RenovoRX, Inc. (RNXT) Press Releases https://ir.renovorx.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/renovorx/files/theme/images/logo-sm.png RenovoRX, Inc. Logo Equisolve Investor Relations Suite <![CDATA[RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting]]> https://ir.renovorx.com/news-events/press-releases/detail/159/renovorx-announces-pharmacokinetic-and-pharmacodynamic-data Thu, 23 Apr 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/159/renovorx-announces-pharmacokinetic-and-pharmacodynamic-data <![CDATA[Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting]]> https://ir.renovorx.com/news-events/press-releases/detail/158/clinical-data-supporting-targeted-chemotherapeutic-delivery Tue, 14 Apr 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/158/clinical-data-supporting-targeted-chemotherapeutic-delivery <![CDATA[RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum]]> https://ir.renovorx.com/news-events/press-releases/detail/157/renovorx-secures-first-notice-of-allowance-for-japanese Wed, 08 Apr 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/157/renovorx-secures-first-notice-of-allowance-for-japanese <![CDATA[RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026]]> https://ir.renovorx.com/news-events/press-releases/detail/156/renovorx-named-to-fast-companys-annual-list-of-the Wed, 01 Apr 26 14:20:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/156/renovorx-named-to-fast-companys-annual-list-of-the <![CDATA[RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update]]> https://ir.renovorx.com/news-events/press-releases/detail/155/renovorx-reports-full-year-2025-financial-results-and Mon, 30 Mar 26 16:05:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/155/renovorx-reports-full-year-2025-financial-results-and <![CDATA[RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment]]> https://ir.renovorx.com/news-events/press-releases/detail/154/renovorx-announces-key-phase-iii-milestone-tiger-pac-trial Thu, 26 Mar 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/154/renovorx-announces-key-phase-iii-milestone-tiger-pac-trial <![CDATA[RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement]]> https://ir.renovorx.com/news-events/press-releases/detail/153/renovorx-announces-closing-of-oversubscribed-10-million-at Mon, 23 Mar 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/153/renovorx-announces-closing-of-oversubscribed-10-million-at <![CDATA[RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET]]> https://ir.renovorx.com/news-events/press-releases/detail/152/renovorx-to-host-fourth-quarter-and-full-year-2025 Fri, 20 Mar 26 08:30:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/152/renovorx-to-host-fourth-quarter-and-full-year-2025 <![CDATA[RenovoRx Announces $10 Million at Market Private Placement]]> https://ir.renovorx.com/news-events/press-releases/detail/151/renovorx-announces-10-million-at-market-private-placement Wed, 18 Mar 26 08:35:00 -0400 https://ir.renovorx.com/news-events/press-releases/detail/151/renovorx-announces-10-million-at-market-private-placement <![CDATA[RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum]]> https://ir.renovorx.com/news-events/press-releases/detail/150/renovorx-advancing-renovocath-adoption-at-u-s-cancer Fri, 27 Feb 26 08:30:00 -0500 https://ir.renovorx.com/news-events/press-releases/detail/150/renovorx-advancing-renovocath-adoption-at-u-s-cancer